ATE441420T1 - Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen - Google Patents
Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungenInfo
- Publication number
- ATE441420T1 ATE441420T1 AT02292963T AT02292963T ATE441420T1 AT E441420 T1 ATE441420 T1 AT E441420T1 AT 02292963 T AT02292963 T AT 02292963T AT 02292963 T AT02292963 T AT 02292963T AT E441420 T1 ATE441420 T1 AT E441420T1
- Authority
- AT
- Austria
- Prior art keywords
- subject
- gamma delta
- regulating
- immune response
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02292963A EP1426052B1 (de) | 2002-12-02 | 2002-12-02 | Interleukin-2 und Gamma Delta T Zellaktivator enthaltende Zusammensetzungen und deren Verwendungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE441420T1 true ATE441420T1 (de) | 2009-09-15 |
Family
ID=32309486
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02292963T ATE441420T1 (de) | 2002-12-02 | 2002-12-02 | Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen |
AT03768074T ATE459360T1 (de) | 2002-12-02 | 2003-12-02 | Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03768074T ATE459360T1 (de) | 2002-12-02 | 2003-12-02 | Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen |
Country Status (8)
Country | Link |
---|---|
US (2) | US20060194755A1 (de) |
EP (2) | EP1426052B1 (de) |
JP (1) | JP2006510629A (de) |
AT (2) | ATE441420T1 (de) |
AU (1) | AU2003292492B2 (de) |
CA (1) | CA2507011A1 (de) |
DE (2) | DE60233576D1 (de) |
WO (1) | WO2004050096A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836483B1 (fr) * | 2002-02-22 | 2006-09-15 | Innate Pharma | Procedes de production de lymphocytes gamma delta t |
US20100291118A1 (en) * | 2003-12-02 | 2010-11-18 | Innate Pharma | Class of Gamma Delta T Cells Activators and Use Thereof |
EP1689758A2 (de) * | 2003-12-02 | 2006-08-16 | Innate Pharma | Neue klasse von aktivatoren von gamma-delta-t-zellen und deren verwendung |
EP1720567A2 (de) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Zusammensetzung und verfahren zur behandlung von karzinomen |
CA2564562A1 (en) | 2004-04-26 | 2005-11-03 | Innate Pharma | Adjuvant composition and methods for its use |
US20090208517A1 (en) * | 2004-08-19 | 2009-08-20 | Bernhard Moser | Preparation Of Antigen-Presenting Human Gamma-Delta T Cells And Use In Immunotherapy |
DK1778836T3 (da) * | 2004-08-19 | 2010-11-22 | Univ Cardiff | Fremstilling af antigenpræsenterende humane gammadelta-T-celler og anvendelse ved immunterapi |
US8012949B2 (en) | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
WO2006039721A2 (en) | 2004-10-08 | 2006-04-13 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
BRPI0608926A2 (pt) * | 2005-03-22 | 2010-11-03 | Innate Pharma | ativador de células t gamadelta, composição farmacêutica, uso de um ativador de células t gamadelta, composição de vacina, método de ativação de uma célula t gamadelta, célula t gamadelta, e, uso de uma célula t gamadelta |
US8338173B2 (en) * | 2005-08-11 | 2012-12-25 | University College Cardiff Consultants Limited | Preparation of antigen-presenting human γδ T cells and use in immunotherapy |
EP2001486A4 (de) | 2006-03-17 | 2010-12-29 | Univ Illinois | Biphosphonat-verbindungen und entsprechende verfahren |
US20100144678A1 (en) * | 2007-04-09 | 2010-06-10 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for treating bone cancer |
US20100189681A1 (en) * | 2007-06-01 | 2010-07-29 | Innate Pharma S.A. | Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer |
US8012466B2 (en) | 2008-01-31 | 2011-09-06 | University Of Iowa Research Foundation | Immunogenic compositions for activating γδ T cells |
EP2123285A1 (de) | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosid-Phosphorantigene zur Verwendung in der VGAMMA9VDELTA2-T-Zellen-vermittelten Therapie |
EP2324040B1 (de) | 2008-09-10 | 2014-01-01 | Innate Pharma | Neue polymorphe form von chdmapp, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält |
WO2010049438A2 (en) * | 2008-10-30 | 2010-05-06 | Innate Pharma | Improved methods of using phosphoantigens for the treatment of diseases |
PL2683395T3 (pl) * | 2011-03-11 | 2019-04-30 | Assist Publique Hopitaux De Paris | Zastosowanie małych dawek il-2 do leczenia cukrzycy typu 1 |
ES2811624T3 (es) * | 2011-03-11 | 2021-03-12 | Hopitaux Paris Assist Publique | Régimen de dosificación de IL-2 para tratar lupus eritematoso sistémico |
EP2916858A1 (de) * | 2012-11-08 | 2015-09-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren zur induzierung von il-2-freier proliferation von gamma-delta-t-zellen |
EP3041494A4 (de) | 2013-09-05 | 2017-10-18 | Sanford-Burnham Medical Research Institute | Modulation von gamma delta t-zellen |
GB201421716D0 (en) | 2014-12-05 | 2015-01-21 | King S College London | Cell expansion procedure |
CN114555785A (zh) * | 2019-10-17 | 2022-05-27 | 香港大学 | 制备v-t细胞衍生的外泌体以治疗epstein-barr病毒相关癌症的方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6896871B2 (en) * | 1998-04-02 | 2005-05-24 | Mbc Research, Inc. | Biphosphonate conjugates and methods of making and using the same |
CA2335791A1 (en) * | 1998-06-30 | 2000-01-06 | Brigham And Women's Hospital, Inc. | Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
ES2254130T3 (es) * | 1999-01-21 | 2006-06-16 | Chugai Seiyaku Kabushiki Kaisha | Sales del acido 2-metil-3-butenil-1-pirofosforico y agentes para tratar linfocitos. |
FR2791981B1 (fr) * | 1999-04-06 | 2001-07-20 | Inst Nat Sante Rech Med | Composes inhibant selectivement les lymphocytes tgamma9delta2, et leurs applications |
WO2000071104A2 (en) * | 1999-05-21 | 2000-11-30 | Novartis Ag | Use of bisphosphonic acids for treating angiogenesis |
PT1408984E (pt) * | 2001-07-20 | 2008-12-26 | Bioagency Ag | Compostos organofosforosos para activar células t gama/delta |
US20050042751A1 (en) * | 2001-10-31 | 2005-02-24 | Michel Goldman | Generation and use of new types of dendritic cells |
FR2836483B1 (fr) * | 2002-02-22 | 2006-09-15 | Innate Pharma | Procedes de production de lymphocytes gamma delta t |
EP1720567A2 (de) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Zusammensetzung und verfahren zur behandlung von karzinomen |
-
2002
- 2002-12-02 DE DE60233576T patent/DE60233576D1/de not_active Expired - Lifetime
- 2002-12-02 AT AT02292963T patent/ATE441420T1/de not_active IP Right Cessation
- 2002-12-02 EP EP02292963A patent/EP1426052B1/de not_active Expired - Lifetime
-
2003
- 2003-12-02 EP EP03768074A patent/EP1569656B1/de not_active Expired - Lifetime
- 2003-12-02 WO PCT/IB2003/006375 patent/WO2004050096A2/en active Application Filing
- 2003-12-02 AU AU2003292492A patent/AU2003292492B2/en not_active Ceased
- 2003-12-02 AT AT03768074T patent/ATE459360T1/de not_active IP Right Cessation
- 2003-12-02 JP JP2004556710A patent/JP2006510629A/ja active Pending
- 2003-12-02 CA CA002507011A patent/CA2507011A1/en not_active Abandoned
- 2003-12-02 US US10/537,394 patent/US20060194755A1/en not_active Abandoned
- 2003-12-02 DE DE60331583T patent/DE60331583D1/de not_active Expired - Lifetime
-
2010
- 2010-06-28 US US12/824,685 patent/US20100254940A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1569656A2 (de) | 2005-09-07 |
WO2004050096A3 (en) | 2004-09-16 |
EP1426052A1 (de) | 2004-06-09 |
DE60331583D1 (de) | 2010-04-15 |
WO2004050096A2 (en) | 2004-06-17 |
EP1569656B1 (de) | 2010-03-03 |
AU2003292492A1 (en) | 2004-06-23 |
US20060194755A1 (en) | 2006-08-31 |
DE60233576D1 (de) | 2009-10-15 |
US20100254940A1 (en) | 2010-10-07 |
ATE459360T1 (de) | 2010-03-15 |
JP2006510629A (ja) | 2006-03-30 |
EP1426052B1 (de) | 2009-09-02 |
AU2003292492B2 (en) | 2008-10-23 |
CA2507011A1 (en) | 2004-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE441420T1 (de) | Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen | |
IL172613A0 (en) | Pan-kir2dl nk-receptor antibodies and their use in diagnostic and therapy | |
MY155909A (en) | Oral care compositions and methods | |
ES2182850T3 (es) | Procedimientos y composiciones para la microencapsulacion de adyuvantes. | |
DE60314565D1 (de) | Kosmetische Hautpflegezusammensetzungen | |
EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
DE60232660D1 (de) | Humane dr4-antikörper und deren anwendungen | |
CY1110437T1 (el) | Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c | |
BRPI0317064B8 (pt) | composições compreendendo células dendríticas parcialmente amadurecidas in vitro | |
BR0307071A (pt) | ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico | |
MXPA02004933A (es) | Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides. | |
ATE311191T1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
ATE527377T1 (de) | Erstellung von genexpressionprofilen aus ffpe- proben | |
YU38103A (sh) | Nova jedinjenja askorbinske kiseline, postupci sinteze i način njihove primene | |
ATE447968T1 (de) | Impfung mit immunisolierten und einen immunomodulator produzierenden zellen | |
DE50310932D1 (de) | Sporopollenin enthaltende lösliche zusammensetzung und verwendung | |
AU2003245989A8 (en) | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases | |
JP2003528139A5 (de) | ||
SG165996A1 (en) | Combination therapies with l-fmau for the treatment of hepatitis b virus infection | |
DE60336504D1 (de) | 4-hydroxypiperidin-derivate zur verwendung als antimycobakterielle mittel | |
NO20052379L (no) | Nye antitumorale forbindelser | |
ATE332141T1 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten | |
DE60203895D1 (de) | Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie | |
ATE551317T1 (de) | Verbindungen, die die glucosenutzung stimulieren, und anwendungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |